Focus Diagnostics Awaits CE Mark, FDA Clearance for Combined Flu/RSV Test on 3M Instrument
August 26, 2010
Focus Diagnostics Awaits CE Mark, FDA Clearance for Combined Flu/RSV Test on 3M Instrument
Focus and 3M are also developing a version of the influenza A/B/RSV test, as well as a test for herpes simplex virus, that would be suitable for use in moderate-complexity laboratories under the Clinical Laboratory Improvement Amendments act.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- PCR Probe Licensing Pact with Focus Diagnostics Portends 'Busy Year' for Evogen
March 14, 2013 / PCR Insider - Quest's Focus Dx Business Gets FDA OK, CE Mark for Flu A/B and RSV Test on 3M Cycler
December 2, 2010 / PCR Insider - FDA Clears Focus Diagnostics' Flu Test on 3M Integrated Cycler
October 9, 2012 / GenomeWeb Daily News - Dx Focus: OraSure Gets FDA OK for DNA Collection Device; Quest Dengue Test Approved in Brazil
December 8, 2011 / PCR Insider - Quest's Focus Diagnostics Launches Nucleic Acid Extraction-Free Flu/RSV Test in Europe
November 3, 2011 / PCR Insider